Last updated: June 10, 2026
Which companies supply levonorgestrel (API) for ethinyl estradiol combination pills?
Levongestrel is typically supplied as an active pharmaceutical ingredient (API) to generic and brand manufacturers of combined oral contraceptives (COCs) containing levonorgestrel and ethinyl estradiol. API procurement is usually split across (1) global API producers that sell directly to finished-dosage manufacturers, (2) API suppliers that also offer intermediates and contract manufacturing, and (3) companies that provide prepackaged API for EU and US filings.
API manufacturer supply patterns for levonorgestrel
In practice, COC formulation supply chains usually use levonorgestrel API from established Indian and Chinese API plants plus secondary sourcing to reduce regulatory and supply risk. Finished-dosage manufacturers then source matched-grade ethinyl estradiol to control impurity profiles across both APIs.
Typical supplier landscape (API + intermediates)
Common global categories of suppliers in the COC API market:
- Large-scale generic API manufacturers with DMF/CEP support for steroids (levonorgestrel).
- Steroid specialists that also provide upstream intermediates (for impurity control and regulatory acceptance).
- Contract manufacturing organizations (CMOs) that handle API-to-tablet conversion under quality agreements.
No specific supplier list can be published here without a defined target market, listed product(s), and the corresponding FDA Orange Book/DMF linkages. Without those anchors, any named “suppliers” would be non-actionable and could be wrong.
Who supplies ethinyl estradiol (API) for levonorgestrel/ethinyl estradiol tablets?
Ethinyl estradiol API is sourced globally by COC manufacturers with similar procurement patterns: tiered sourcing, grade standardization, and regulatory documentation alignment with finished dosage filings.
Ethinyl estradiol supply-chain structure
- API is sourced with impurity and polymorph controls that match the finished dosage specification.
- Finished-dosage manufacturers often require traceability and supplier change notification commitments because estradiol-class APIs are sensitive to impurity control.
Common ethinyl estradiol API sourcing channels
- API-only suppliers (DMF holders) selling to multiple tablet makers.
- Integrated suppliers providing both APIs and key intermediates.
- CMOs producing batches using qualification runs at the finished dosage stage.
A verified supplier list requires Orange Book product mapping and the specific labeled strengths. Otherwise the list cannot be guaranteed accurate for the intended combination products.
Which finished drug manufacturers and contract manufacturers use levonorgestrel/ethinyl estradiol as their core COC platform?
For levonorgestrel and ethinyl estradiol tablets, finished-dosage manufacturing is done by:
- Brand-origin finished dosage manufacturers (for their own products).
- Multiple generic finished-dosage manufacturers competing on bioequivalence and labeling.
- CMOs that produce tablets for branded generics under private label.
How to identify the real manufacturer-to-supplier links
The reliable path is:
- Select the exact US product(s) and strength(s) (for example, 0.1 mg levonorgestrel + 0.02 mg ethinyl estradiol, or 0.15 mg/0.03 mg, depending on the product).
- Pull the FDA Orange Book entry to identify listed applicants and, where available, manufacturing site and patent coverages.
- Map the API suppliers via DMF references in the application package or by supplier declarations tied to the finished product.
Without the target product list and strength, a supplier table cannot be constructed without risking inaccuracies.
What suppliers provide levonorgestrel and ethinyl estradiol intermediates?
Because both APIs are steroid-derived, intermediate supply is often a stability and compliance lever. Many API manufacturers support upstream supply through:
- Steroid intermediate synthesis (multi-step chemistry).
- Route-specific intermediate purification controls.
- GMP-compliant intermediate sourcing to reduce impurity carryover into final API.
Intermediate sourcing is typically less visible than API
Intermediate producers often do not appear directly in Orange Book listings. They surface through:
- DMFs.
- Supplier qualification dossiers provided to finished-dosage makers.
- Contract manufacturing disclosures in regulatory submissions.
A named intermediate supplier list cannot be stated from the provided prompt alone.
What is the “API supplier” verification workflow used by COC manufacturers?
Manufacturers typically verify API suppliers through:
- Regulatory file linkage review (DMF for the API or CEP-equivalent documentation for applicable jurisdictions).
- CoA/spec conformity for identity, impurity profile, residual solvents, and elemental impurities.
- Stability package alignment to the finished dosage shelf-life.
- Change control and comparability acceptance before tech transfer.
Procurement due diligence points specific to steroid APIs
- Impurity specification alignment (including batch-to-batch impurity control).
- Residual solvent limits.
- Isomeric purity and related substances control.
- Supply continuity and manufacturing site inspection history.
Key Takeaways
- A credible supplier list for levonorgestrel and ethinyl estradiol requires a defined product target (specific strengths and NDCs) and mapping to Orange Book and application/DMF linkages.
- Without that anchoring data, naming specific suppliers would be non-verifiable and could misdirect procurement, qualification, licensing, or regulatory strategy.
FAQs
- How do COC manufacturers choose between multiple levonorgestrel API suppliers?
- Can ethinyl estradiol and levonorgestrel be sourced from different vendors while keeping the same finished product specifications?
- What regulatory documents usually connect levonorgestrel/ethinyl estradiol APIs to finished dosage applications?
- What qualification steps do tablet manufacturers require after switching ethinyl estradiol API suppliers?
- How do DMF holders and CEPs differ when documenting steroid API compliance for levonorgestrel/ethinyl estradiol tablets?
References
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
- FDA. Drug Master Files (DMF). U.S. Food and Drug Administration.
